89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding 89bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 49 | 48 | −1 |
| Shares | 16.9M | 17.3M | +464.7K (+2.8%) |
| Value | $315.2M | $339.4M | +$24.2M (+7.7%) |
New holders (3)
Institutions that held 89bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 27,531 | $539.0K | 0.05% |
| SG Americas Securities, LLC | 5,661 | $111.0K | 0.00% |
| Ellevest, Inc. | 3 | $0 | 0.00% |
Sold out (4)
Institutions that held 89bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Silverarc Capital Management, LLC | 28,032 | $524.0K |
| Penn Mutual Asset Management, LLC | 16,190 | $303.0K |
| Goldman Sachs Group Inc | 12,525 | $234.0K |
| Wells Fargo & Company | 123 | $2.00K |